TMDX

TransMedics Group, Inc. Common Stock

135.81

USD

TMDX Earnings Reports

Positive Surprise Ratio

TMDX beat 17 of 27 last estimates.

63%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

$158.83M

$0.39

Implied change from Q3 25 (Revenue/ EPS)

+10.44%

-40.91%

Implied change from Q4 24 (Revenue/ EPS)

+30.59%

+105.26%

TransMedics Group, Inc. Common Stock earnings per share and revenue

On Oct 29, 2025, TMDX reported earnings of 0.66 USD per share (EPS) for Q3 25, beating the estimate of 0.35 USD, resulting in a 84.41% surprise. Revenue reached 143.82 million, compared to an expected 148.16 million, with a -2.93% difference. The market reacted with a +1.09% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 14 analysts forecast an EPS of 0.39 USD, with revenue projected to reach 158.83 million USD, implying an decrease of -40.91% EPS, and increase of 10.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Thermo Fisher Scientific, Inc.

Report Date

Jan 29, 2026 For Q4 25

Estimate

$6.51

Actual

$6.57

Surprise

+0.91%

Intuitive Surgical Inc.

Report Date

Jan 22, 2026 For Q4 25

Estimate

$2.30

Actual

$2.52

Surprise

+9.86%

Idexx Laboratories Inc

Report Date

Feb 02, 2026 For Q4 25

Estimate

$2.98

Actual

$3.08

Surprise

+3.09%

Hologic Inc

Report Date

Jan 29, 2026 For Q1 26

Estimate

$1.11

Actual

$1.04

Surprise

-6.63%

Mesa Laboratories Inc

Report Date

Feb 03, 2026 For Q3 26

Estimate

$0.28

Actual

$3.07

Surprise

+987.88%

FAQ

What were TransMedics Group, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, TransMedics Group, Inc. Common Stock reported EPS of $0.66, beating estimates by 84.41%, and revenue of $143.82M, -2.93% below expectations.

How did the market react to TransMedics Group, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 1.09%, changed from $134.32 before the earnings release to $135.79 the day after.

When is TransMedics Group, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for TransMedics Group, Inc. Common Stock's next earnings report?

Based on 14 analysts, TransMedics Group, Inc. Common Stock is expected to report EPS of $0.39 and revenue of $158.83M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.